Chicken-Free Egg Protein Enters Major US Grocery Stores
Washington, Friday, 21 August 2026.
Yeast-derived egg protein is expanding into major U.S. retailers like Walmart and Target after demand surged 550% in early 2026, marking a major milestone for food technology.
Retail Expansion of Precision-Fermented Proteins
Precision-fermented egg proteins have quietly entered major retail shelves across the United States, including Walmart, Target, and Amazon, as of August 2026 [1][3]. The commercial deployment highlights a significant shift in the food supply chain, with products containing recombinant ovalbumin now available in all 50 U.S. states [1]. The EVERY Company, formerly known as Clara Foods, is a primary producer of this ingredient, marketed under the trade name OvoPro [2][4]. While the technology has been in development since at least 2014, the widespread retail presence marks a new phase of market penetration for animal-free proteins [2].
Retail Expansion of Precision-Fermented Proteins
Consumers encountering these products may find them labeled as animal-free egg white protein or similar variations, though specific brand names containing the ingredient often remain contractually confidential [1][5]. The ingredient is produced using genetically engineered yeast, specifically Komagataella phaffii, which is programmed to produce egg-white protein during fermentation [2][3]. Despite the biological engineering involved, the final product is certified vegan, although it retains the classification of an egg allergen under federal law [1][4].
Regulatory Landscape and Safety Clearance
Contrary to some social media claims, these products have not undergone formal FDA approval in the same manner as pharmaceutical drugs [2]. Instead, The EVERY Company utilized the Generally Recognized as Safe (GRAS) regulatory pathway, receiving a no questions letter from the FDA on October 17, 2023 [1][2]. This regulatory distinction is critical, as the FDA’s response indicates no objections to the safety conclusion rather than an affirmative certification of the product [1][4]. The agency noted that the review did not address other provisions of the FD&C Act beyond the GRAS status [1].
Regulatory Landscape and Safety Clearance
The regulatory pathway allows for the use of precision-fermented proteins in a wide range of products, including baked goods and plant-based meat alternatives [1]. However, the ingredient is explicitly not cleared for use in infant formula or products under USDA jurisdiction [1]. Federal regulations mandate that packaged foods containing OvoPro must identify the ingredient by its common or usual name on the label to avoid violations [4]. This ensures that while the production method is novel, the labeling adheres to existing food safety standards requiring accurate ingredient listing [2].
Market Demand and Production Scaling
Demand for the yeast-derived protein has surged dramatically, with annual orders secured during the first four months of 2026 reaching 5.5 * 2025_volume of the company’s total order volume for the entirety of 2025 [1][3]. This 550% increase in orders prompted The EVERY Company to quadruple its production capacity as of June 2026 [3][4]. To meet this demand, the company expanded its partnership with Huvepharma’s Biovet AD in Bulgaria, securing over 9 million liters of fermentation capacity [1].
Market Demand and Production Scaling
Further commercial-scale production is planned for Clinton, Iowa, through a partnership with ADM signed in July 2026 [1]. The EVERY Company raised 55 million dollars in a Series D funding round announced on October 28, 2025, to support these expansion efforts [1]. Investors in this round include Minerva Foods and ADM, signaling strong institutional confidence in the scalability of precision fermentation technologies [1]. This capital infusion supports the transition from niche availability to mainstream retail distribution observed in August 2026 [3][5].
Labeling Transparency and Consumer Information
Regarding transparency, The EVERY Company confirmed on August 21, 2026, that it has not sought exemptions from federal ingredient labeling requirements for OvoPro [2]. While the trade name OvoPro is used with manufacturers, retail labels typically list the ingredient by its common name, such as animal-free egg white protein [2][5]. Claims circulating on social media alleging that brands are hiding the use of this ingredient are unfounded, as federal law requires accurate ingredient listing ranked in descending order by weight [2].
Labeling Transparency and Consumer Information
The product remains classified as an egg allergen and requires a Contains: Egg label under the FD&C Act, despite being certified vegan [1][4]. This dual classification ensures consumer safety for those with egg allergies while maintaining the vegan certification based on the production method [1]. As the market continues to evolve, the distinction between precision fermentation and cell-cultured meat remains a key point of regulatory and consumer education [2][4].